L

LiberaBio

9 employees

Addressing “undruggable intracellular targets” in oncology

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Active targeting
Life Science
Biopharma
Biosimilars
Oncology
Antibodies
Oncoproteins
Drug delivery
Cytotoxics
Intracellular
Nanomedicine

Date founded

2018

Funding rounds raised

Total raised

$1.3M

from 3 investors over 3 rounds

L

LiberaBio raised $1.3M on July 19, 2022

Investors: Innova-Tech Consulting and Xesgalicia, Sociedad Gestora de Entidades de Inversión de Tipo Cerrado, S.A.U.

L

LiberaBio raised undisclosed on December 23, 2021

Investors: Xesgalicia, Sociedad Gestora de Entidades de Inversión de Tipo Cerrado, S.A.U.

FAQ